The contribution of adrenoceptor subtype (s) in the renal vasculature of diabetic spontaneously hypertensive rats

British Journal of Pharmacology

Volumn 142, Issue 4, 2004, Pages 719-726

  Armenia, A ^a   Munavvar, A S ^a   Abdullah, N A ^b   Helmi, A ^a   Johns, E J ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Alpha adrenoceptor subtypes; Renal vasoconstriction; Spontaneously hypertensive rats; Streptozotocin induced diabetes

Indexed keywords

5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; METHOXAMINE; NITRENDIPINE; NORADRENALIN; PENTOBARBITAL; PHENYLEPHRINE; STREPTOZOCIN;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; ELECTROSTIMULATION; GLUCOSE BLOOD LEVEL; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY NERVE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASOCONSTRICTION;

ANIMALS; BLOOD GLUCOSE; CLONIDINE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTRIC STIMULATION; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY CORTEX; MALAYSIA; MALE; METHOXAMINE; MUSCLE, SMOOTH, VASCULAR; NITRENDIPINE; NOREPINEPHRINE; PHENYLEPHRINE; PIPERAZINES; RATS; RATS, INBRED SHR; RECEPTORS, ADRENERGIC, ALPHA-1; STREPTOZOCIN; TIME FACTORS; VASOCONSTRICTION;

EID: 3242786574     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705842     Document Type: Article

References (57)

1. BEENEN, O.K., MATHY, M.J., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (1996). Vascular responsiveness in isolated perfused kidneys of diabetic hypertensive rats. J. Hypertens., 14, 1125-1130.
2. 1A-adrenoceptors in rat kidney. Br. J. Pharmacol., 107, 414-417.
3. 1C-adrenoceptor: studies in isolated perfused kidney of rat. Br. J. Pharmacol., 115, 283-294.
4. ++ channels and to a subtype of alpha1-adrenoceptors. Eur. J. Pharmacol., 297, 241-248.
5. BYLUND, D.B., EIKENBERG, D.C., HIEBLE, J.P., LANGER, S.Z., LEFKOWITZ, R.J., MINNEMAN, K.P., MOLINOFF, P.B., RUFFOLO JR, R.R. & TRENDELENBURG, U. (1994). Nomenclature of adrenoceptors. Pharmacol. Rev., 46, 121-136.
6. 1 receptors. J. Pharmacol. Exp. Ther., 230, 413-418.
7. 1-adrenoceptors in rat kidney: agonists and antagonists [prazosin, WB 4101, (+) niguldipine] characterization. Eur. J. Pharmacol., 183, 733.
8. 1B-adrenoceptor. Biochem. Soc. Trans., 23, 121-125.
9. DE MEY, J.G.R. (1997). Alpha 1-adrenoceptors in the arterial system: relation to adrenergic nerves. J. Auton. Pharmacol., 7, 211-213.
10. DIBONA, G.F. & KOPP, U.C. (1997). Neural control of renal function. Physiol. Rev., 77, 75-197.
11. 1 agonist-induced vasoconstriction in diabetes. J. Surg. Res., 70, 119-123.
12. 1-adrenoceptor alkylation in the rat kidney and its effect on the vascular pressor response. J. Pharmacol. Exp. Ther., 260, 709-716.
13. 1A-adrenoceptors. Eur. J. Pharmacol., 202, 33-44.
14. FAURE, C., PIMAULE, C., ARBILLA, S., LANGER, S.Z. & GRAHAM, D. (1994). Expression of α1-adrenoceptor subtypes in rat tissues, implications for α1-adrenoceptor classification. Eur. J. Pharmacol., 268, 141-149.
15. FENG, F, PETTINGER, W.A., ABEL, P.W. & JEFFRIES, W.B. (1991). Regional distribution of alpha 1-adrenoceptor subtypes in rat kidney. J. Pharmacol. Exp. Ther., 258, 263-268.
16. FORD, A.P.W.D. (1994). α1-adrenoceptor classification: sharpening Occam's razor. TiPS, 15, 167-170.
17. 1-adrenergic receptor that mediate smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha1C subtype. Mol. Pharmacol., 45, 703-708.
18. GARCIA, V.M.C., OCHOA, J.E. & ELIAS, M.M. (1999). Effect of early stage of experimental diabetes on vascular functions in isolated perfused kidneys. J. Auton. Pharmacol., 18, 97-103.
19. 1-adrenoceptor action: receptor subtypes signal transduction and regulation. Cell. Signal., 5, 539-547.
20. 1-adrenoceptors. Eur. J. Pharmacol., 272, R5-R6.
21. 1-adrenoceptor. Eur. J. Pharmacol., 151, 333-335.
22. ++ in smooth muscle. Nature, 329, 333-335.
23. 1-adrenoceptors in rat blood vessels. Eur. J. Pharmacol., 190, 97-104.
24. 1-adrenoceptors: consensus update. Pharmacol. Rev., 47, 267-270.
25. JACKSON, C.V. & CARRIER, G.O. (1981). Supersensitivity of isolated mesenteric arteries to noradrenaline in the long-term experimental diabetic rat. J. Anton. Pharmacol., 1, 399-405.
26. 1-adrenoceptor subtypes in established hypertension. J. Cardiovasc. Pharmacol., 19, 857-862.
27. 1-adrenoceptor memdiataing renal nerve induced calcium reabsorption by the kidney. Br. J. Pharmacol., 89, 91-97.
28. 1A-adrenergic receptors linked to phosphatidylinositol turnover and cyclic AMP accumulation in rat brain. Mol. Pharmacol., 31, 239-246.
29. KAM, K.L., HENDRIKS, M.G., PIJL, A.J., VAN MARLE, J., VAN VEEN, H.A., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (1996). Contractile responses to various stimuli in isolated resistance vessels from simultaneously hypertensive and streptozotocin-diabetic rats. J. Cardiovasc. Pharmacol., 27, 167-175.
30. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol., 115, 981-986.
31. 1-adrenoceptor subtypes mediating constraction of the rabbit ear thermoregulatory microvasculature. J. Orthop. Res., 18, 150-163.
32. MICHEL, A.D., LOURY, D.N. & WHITING, R.L. (1989). Identification of a single alpha 1-adrenoceptor corresponding to the alpha1A-subtype in rat submaxillary gland. Br. J. Pharmacol., 98, 883-889.
33. 1A-adrenergic receptor subtypes distinguished by chloroethylclonidine and WB 4101. Mol. Pharmacol., 53, 509-514.
34. 3H] prazosin binding. Mol. Pharmacol., 29, 321-330.
35. OWEN, M.P. & CARRIER, G.O. (1979). Alteration in vascular muscle sensitivity to vasoconstrictor agent by streptozotocin induced diabetes. Proc. West. Pharmacol. Soc., 22, 363-366.
36. OWEN, M.P. & CARRIER, G.O. (1980). Calcium dependence of norepinephrine-induced vascular contraction in experimental diabetes. J. Pharmacol. Exp. Therap., 212, 253-258.
37. PACKER, M. (1992). Pathophysiological of chronic heart failure. Lancet, 340, 38-92.
38. PATEL, K.P. & ZHANG, P.L. (1994). Reduced renal sympathoinhibition in response to volume expansion in diabetic rats. Am. J. Physiol., 267, R372-R379.
39. 1A subtype. Pharmacology, 46, 823-831.
40. 1D-adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. Ther., 275, 1583-1589.
41. PIASCIK, M.T., SPARKS, M.S. & PRUITT, T.A. (1992). Effect of chloroethylclonidine on arterial blood pressure and heart rate in concious rat. J. Pharmacol. Exp. Ther., 263, 901-906.
42. 1-adrenoceptors in the rat renal vasculature. Br. J. Pharmacol., 104, 318P.
43. 1- adrenoceptor subtype mediating adrenergic vasoconstriction in Wistar normotensive and stroke-prone spontaneously hypertensive rat kidney. J. Cardiovasc. Pharmacol., 23, 232-239.
44. 1-adrenoceptor subtype mediating adrenergic vasoconstriction in kidney of 2K1C Goldblatt and DOCA-salt hypertensive rats. J. Cardiovasc. Pharmacol., 24, 420-428.
45. SCHWARTZ, D.D. & EIKENBURG, D.C. (1988). Enhanced endogenous neurotransmitter overflow in the isolated perfused rat kidney after chronic epinephrine administration: lack of a prejunctional beta adrenoceptor influence. J. Pharmacol. Exp. Ther., 244, 11-18.
46. SCHWARTZ, D.D. & MALIK, K.U. (1989). Renal periarterial stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat. J. Pharmacol. Exp. Ther., 107, 414-417.
47. 1-adrenoceptor subtypes: selective antagonists suggest the existence of a fourth subtype. Eur. J. Pharmacol., 227, 433-436.
48. 1A-adrenoceptors in rat arteries. J. Pharmacol. Exp. Ther., 284, 399-405.
49. SUMMERS, R.J. (1984). Renal α-adrenoceptors. Fed. Proc., 43, 2917-2922.
50. ++ signaling mechanism and plays a different physiological rol. J. Pharmacol. Exp. Ther., 38, 725-736.
51. TAKATA, Y. & KATO, H. (1996). Adrenoceptor in SHR: interaction in binding characteristics and intracellular signal transduction pathways. Life Sci., 58, 91-106.
52. TESFAMARIAM, B. & COHEN, R.A. (1995). Enhanced adrenergic neurotransmssion in diabetic rabbit carotid artery. Cardiovasc. Res., 29, 549-554.
53. ++ influx. J. Pharmacol. Exp. Ther., 36, 166-176.
54. 1A subtypes. Eur. J. Pharmacol., 298, 257-263.
55. 1A-adrenoceptors mediate contraction of rat renal artery. Eur. J. Pharmacol., 322, 225-227.
56. 1-adrenoceptors in hindlimb vascular bed of spontaneously hypertensive rats and their effect on oxygen consumption. J. Pharmacol. Exp. Ther., 286, 588-606.
57. ZHONG, H. & MINNEMAN, K.P. (1999). Alpha1-adrenoceptor subtypes. Eur J. Pharmacol., 375, 261-276.